Folie 1

advertisement

Nature, 24 July 2008; 454(7203):523-527

05.01.2009, Wiebke Albrecht

Innate immunity and virus recognition

 innate immunity is characterized by the use of pattern recognition receptors (PRRs)

 PRRs recognize pathogenassociated molecular patterns

(PAMPS)

 PRR activation leads to type I interferon (IFN) and proinflammatory cytokine production

 3 types: toll-like receptors (TLRs)

RIG-I-like receptors (RLRs)

NOD-like receptors

RIG-I = retinoic acid-inducible gene I

NOD = nucleotide-binding oligomerization domain

PRRs induce type I IFN and proinflammatory cytokines

Saito et al. (2008), commentary

RIG-I

 located in the cytoplasm

 consists of a DEXD/H box helicase domain, two CARD-like domains required for activation of downstream signalling pathways and a C-terminal domain (CTD) that includes a repressor domain (RD) inhibiting signalling in the steady state

 recognizes short dsRNA and 5‘ terminal triphosphate RNA (5‘ ppp RNA) binding of nonself RNA to RIG-I leads to a conformational change, the CARD domains are exposed and activate downstream signalling

CARD = caspase-recruiting domain

Model of RIG-I activation

Yoneyama et Fujita (2008)

Hepatitis C virus (HCV)

 small enveloped virus (diameter ~50nm)

 (+) ssRNA genome

 genus: Hepacivirus family: Flaviviridae

 causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma

 six major genotypes are known, differing in their geographic distribution and their responsiveness to antiviral therapy

HCV life cycle

Lindenbach et al. (2005)

HCV genome

 genome size: ~9,6 kb

 genome encodes one ORF which is translated as a polyprotein and subsequently cleaved into ten proteins

 5‘ NTR is a conserved region and consists of four domains, including an IRES element to direct cap-independent translation

 3‘ NTR consists of 3 domains sufficient for replication

HCV polyprotein

Bode et al. (2008)

ORF = open reading frame

NTR = non-translated region

Identification of HCV PAMP RNA motifs

 luciferase reporter assay with a reporter plasmid containing an IFNβ promotor

 carried out in Huh7 cells (human hepatoma cell line) two regions inducing the IFNβ promotor, further mapping of the responsible regions

IFN = interferon

ORF 3‘ NTR

 further mapping to nt 2406-

2696 of the ORF and to nt

93899616 of the 3‘ NTR

 deletion of of the 3‘ NTR but not deletion of the region nt 2408-2663 attenuated promotor signalling

 PAMP motifs are typically conserved, nt 9389-9616 show high conservation between different HCV starins nt = nucleotides

Structure of the HCV 3‘ NTR

VR = variable region with potential secondary structure (~40 nt)

PU/UC = non-structured poly (U/UC) tract containing polyuridine with interspersed ribocytidine (variable length)

X = highly conserved segment that formes 3 stemloop structures (~98 nt)

RI = replication intermediate (- RNA strand)

HCV PAMP in the viral 3‘ NTR

 reporter assay in Huh7

 PU/UC region is sufficient for signal triggering

 also shown in Hela cells

IRF = interferon regulatory factor

ISG = antiviral/interferon-stimulated gene

 full legth 3‘ NTR as well as PU/UC region stimulated the formation of active IRF3 dimers and expression of ISG56, an IRF3 target gene (shown by immunoblotting)

 PU/UC region forms a complex with RIG-I, while the X region does not (shown by a gelshift assay)

Induction of IFNβ promotor depends on

RIG-I

 IFNβ promotor induction in

Huh7.5 cells

 Huh7.5 cell lack functional

RIG-I

 cells were refractory to HCV

RNA induced signalling, which was rescued by overexpression of WT RIG-I

Involvement of signalling molecules in IFNβ production

 reporter assays in MEFs (mouse embryonic fibroblasts)

 MDA5 is also a RLR member like RIG-I; MyD88 and TRIF are essential adaptor protein used by TLR 7/8 and 3 recognizing endosomal RNA

 no reporter induction in RIGI negative MEF‘s upon RNA stimulation

 lack of MDA5, MyD88 and Trif does not influence signal induction by full length 3‘ NTR and PU/UC region

HCV PU/UC region co-localizes and interacts with RIG-I

 FRET analysis

 PU/UC RNA co-localizes and interacts with RIG-I

 RIG-I is the essential PRR that signal innate immune responses against HCV triggered by the poly (U/UC) region

HCV RNA requires 5‘ ppp for RIG-I binding and signal triggering

 RIGI binds to PAMP RNA containing 5‘ terminal triphosphate (5‘ ppp)

 5‘ ppp is required for poly (U/UC) RNA binding by RIG-I and for IFN-β signalling, but does not mediated binding of RIG-I to the X region; X region just weakly triggers signalling reporter assay in

Huh7 cells, with and without pre-treatement with IFNβ gel-shift assay

N = N-terminus of RIG-I

FL = full lenght RIG-I

Effect of PU/UC or X RNA on RIG-I activation

 limited trypsin digestion analysis

 upon binding of PAMP RNA the

RIG-I repressor domain (RD) is displaced and present as a single fragment

 binding of PU/UC region to RIG-I rendered the RD fragment

 HCV PU/UC region directs stable interaction with RIGI in a 5‘ ppp dependent manner to activate signalling

Effect of nucleotide composition on IFNβ promotor signalling

 replacement of uridine reduced PAMP signalling

 poly-A is also capable to induce signalling, again replacement leads to reduced signalling

 truncation of the PU/UC region also reduces signalling (not shown)

Effect of nucleotide composition on RIG-I activation

 poly-A RNA as well as PU/UC bind to RIG-I and lead to displacement of the

RD

 signalling can be triggered by polymeric uridine and riboadenine motifs serving as PAMP signature within 5‘ ppp RNA recognized by RIG-I

Induction of IFNβ promotor by PU/UC in vivo

 signalling analysis in WT and

RIG-I -/mice

 intravenous administration of HCV

RNA

 induction of hepatic IFNβ mRNA levels in WT mice, but not RIG-I -/mice, by HCV genome or PU/UC region

HCV PAMP RNA triggers hepatic immune responses (1)

 time course studies

 the PU/UC region induced a peak of hepatic IFNβ mRNA levels and

IFNβ serum levels in WT mice, but not in RIG-I-/- mice

HCV PAMP RNA triggers hepatic immune responses (2)

 the PU/UC region induced also a peak of hepatic RIG-I and ISG56 mRNA levels in WT mice,but not in RIG-I-/- mice

 induction of tissue-wide expression of ISG54 in WT mice suggestingthat paracrine signalling of IFNβ could play a role in hepatic defenses against

HCV

HCV PAMP RNA triggers paracrine antiviral effects of the innate immune response

 measurement of HCV production of infected Huh7.5 cells treated with

IFNβ or conditioned media

(supernatant from cells transfected with the indicated RNA species)

 treatment with IFNβ or supernatant from PU/UCtransfected cells induced a immune response that suppresses HCV infection

 RIG-I signalling triggered by

PU/UC can induce an antiviral response through indirect, paracrine actions of IFN produced from HCV

PAMP signalling pre-treatment with

IFNβ or conditioned media treatment with IFNβ or conditioned media

48h post infection

Summary

 RIG-I signals innate immune responses against HCV triggered by the poly

(U/UC) region of the 3‘ NTR of the HCV genome or ist replication intermediate

 IFNβ production is induced in experiments in vitro and in vivo in response to HCV RNA

 PAMP signature recognized by RIG-I is characterized by polymeric uridine and riboadenine motifs within 5‘ ppp RNA

 5‘ppp on PAMP RNA is necessary but not sufficient for RIG-I binding

 RIG-I signalling triggered by PU/UC can induce a direct as well as a indirect antiviral response through paracrine actions of IFN produced from HCV

PAMP signalling

Thanks for your attention !

Download